T1	Participants 0 99	The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.
T2	Participants 863 953	Under the given conditions, the children failed to learn on either haloperidol or placebo.
T3	Participants 101 470	This double-blind and placebo-controlled clinical trial in autistic children had three objectives: (a) to replicate earlier findings that haloperidol administration is associated with a significant reduction of behavioral symptoms; (b) to further assess its safety when given on a short-term basis; and (c) to assess whether it has an effect on discrimination learning.
